Fluidic Analytics Limited, a spinout from the University of Cambridge, has raised £1.56 million (US$2.4 million) in a Series A financing led by Cambridge Enterprise and including DFJ Esprit, IQ Capital, Parkwalk Advisors and Amadeus Capital Partners as co-investors.

ESADE will develop educational offerings specifically designed to strengthen the executive and leadership skills of digital entrepreneurs

A new drug for ovarian cancer, developed by researchers at the University of Cambridge and AstraZeneca, has become the first of new class of drugs, known as PARP-inhibitors, to be granted approval anywhere in the world. The drug, Lynparza, has been granted Marketing Authorisation from the European Commission.

Imperial has the greatest concentration of high impact research of any major UK university, according to the Research Excellence Framework (REF) 2014.

A total of 22 new companies were founded in 2014 by researchers from ETH Zurich. These spin-offs are among the most successful in Switzerland. One of the year's highlights was Covagen, which was acquired for over CHF 200 million. The latest figures also reveal that the university is on the right track with its promotion programmes.

Researchers at University of Bologna designed the first self-assembling molecular motor capable of converting light energy into work. The study was published in Nature Nanotechnology.

Special emphasis was put on good usability in the selection process of the new research information management system.

ETH Zurich and the University of Zurich are founding a new translational research centre at the interface of medicine, science and engineering: the Wyss Translational Center Zurich. A USD 120 million donation from Dr. h.c. mult. Hansjörg Wyss to the two Zurich universities is making this possible. Through an interdisciplinary approach, the new centre aims to accelerate the development and application of innovative medical therapies and groundbreaking robotic systems.

For five years, robotics expert and Executive Board member Roland Siegwart has held the post of Vice President Research and Corporate Relations. He is now in the process of handing over this vice presidency to his successor, Detlef Günther, but he will always remain a firm fan of ETH Zurich.

A leading HIV expert at Imperial College London, Professor Weber has taken up his appointment as Director of the AHSC.